ICP
OGN icon

Ilex Capital Partners’s Organon & Co OGN Stock Holding History

Ilex Capital Partners’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-14,575
Closed -$156K – 137
2025
Q3 		$156K Buy
+14,575
New +$143K 0.01% 135
2025
Q2 		– Sell
-105,370
Closed -$1.57M – 234
2025
Q1 		$1.57M Buy
+105,370
New +$1.62M 0.06% 143

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
KBG
Kahn Brothers Group New York $633M AUM 39.01% 1-Year Est. Return

Ilex Capital Partners's OGN Position: Q4 2025 in Review

Ilex Capital Partners sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 14,575 shares — an estimated $156K sold.

Ilex Capital Partners first reported a position in OGN in Q1 2025 and held it in 2 quarters. The position peaked at $1.57M in Q1 2025. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Ilex Capital Partners reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • Ilex Capital Partners sold 14,575 Organon & Co shares in Q4 2025, an estimated $156K.
  • Ilex Capital Partners first reported a position in Organon & Co in Q1 2025 and held it in 2 quarters.
  • Ilex Capital Partners's Organon & Co position peaked at $1.57M in Q1 2025.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Ilex Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.